Disparities Seen in Biennial Mammography Screening for Women in in Their 40s
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 23, 2024 -- For women aged 40 to 49 years, there are considerable disparities and gaps in biennial mammography screening, according to a research letter published online Dec. 20 in JAMA Network Open.
Tianshu Gu, M.D., from the University of Tennessee Health Science Center in Memphis, and colleagues examined disparities and gaps in breast cancer screening among women aged 40 to 49 years using nationally representative data from the National Health Interview Survey in 2019 and 2021. Mammography screening was self-reported and classified into biennial screening, overdue screening, and no screening.
The researchers found that of the 20.1 million women, 11.7, 3.0, and 5.0 million (weighted percentage, 59.2, 15.2, and 25.6 percent, respectively) reported biennial, overdue, and no screening, respectively. Among several minority groups, the biennial screening rates were significantly lower: non-Hispanic women with other race, lesbian and bisexual women, rural residents, and those with a family income at 138 percent or less of the federal poverty level (FPL). As family income decreased, the rate of biennial screening decreased. The likelihood of overdue screening versus biennial screening was increased in association with lacking a usual place of care (risk difference, 0.07). Factors associated with a higher probability of no screening included being non-Hispanic Asian, having family income based on FPL, being uninsured, and lacking a usual place for care.
"Targeted interventions and policies aimed at enhancing health care access, coverage, and affordability hold significant potential to improve health equity in biennial mammography screening for women aged 40 to 49 years," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-24 06:00
Read more
- Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
- Deep Belly Fat May Help Spur Alzheimer's Decades Before Symptoms Begin
- 2010 to 2022 Saw Drop in Hospital-Based Obstetric Care in U.S. Hospitals
- COVID-19, Flu, RSV Vaccine Coverage Low for Nursing Home Residents
- GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
- Study Finds GLP-1 Meds Can Also Help the Kidneys
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions